Researchers from University of British Columbia and the Lady Davis Institute at the Jewish General Hospital in Montreal studied more than two million statin users.
They found that patients taking higher strength pills were more at risk of suffering acute kidney injury.
They were at a 34 per cent greater danger of being hospitalised with kidney problems within 120 days of starting treatment with high-dose statins than low-dose pills, the Daily Express reported.
"In some cases, patients may be exposed to unnecessary risk of kidney damage for small gains in cardiovascular health. Although the absolute risk of kidney damage with these drugs is low, our findings put into question the common approach of using higher doses to push cholesterol levels lower and lower," author of the Canadian report, Professor Colin Dormuth, said.
"We are not saying don't take statins. If you are giving patients a high dose statin, let's make sure there is a good reason. A high dose might be beneficial for those who have had a heart attack or have high cholesterol, and then they are life-saving," said Dr Pierre Ernst, professor of medicine at the McGill University Centre for Clinical Epidemiology in Montreal, who was involved in the research.
Statins considered to be high potency were rosuvastatin at doses of 10mg or higher, atorvastatin at doses of 20mg or higher, and simvastatin at doses of 40mg or more.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
